Naloxone HCL 4 MG nasal spray 2S
Ended Awarded Last action
- Contract number
- SPE2DR26FG2EN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,014
Award facts
- Contract value 100% obligated
- $3,013.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 14, 2025, for the supply of Naloxone HCL 4 mg nasal spray (2-count packages) with a contract ceiling value of $3,013.92. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded procurement. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 15, 2025. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), which carries a maximum value of $999,999,999 and runs through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA prime contract vehicle provides comprehensive pharmaceutical support globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This naloxone delivery order reflects the company's ongoing role in supplying emergency medical commodities to support Defense Health Agency operations and other federal healthcare systems. The award underscores DLA's reliance on AmerisourceBergen's extensive pharmaceutical distribution capabilities to meet urgent medical supply requirements across the federal government.
Quick answers
Who was awarded contract SPE2DR26FG2EN?
SPE2DR26FG2EN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 14, 2025.
How much is contract SPE2DR26FG2EN worth?
The government has obligated $3,014 on SPE2DR26FG2EN.
Is contract SPE2DR26FG2EN an order under another contract?
Yes. SPE2DR26FG2EN is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG2EN competed?
The extent of competition for SPE2DR26FG2EN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award